Find similiar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL16973/0017.
Meptid Tablets
Meptid 200 mg Film-Coated Tablets
Meptazinol
1. What Meptid Tablets are and what they are used for
2. What you need to know before you take Meptid Tablets
3. How to take Meptid Tablets
4. Possible side effects
5 How to store Meptid Tablets
6. Contents of the pack and other information
This medicine contains meptazinol which is an opioid, which can cause addiction. You can get withdrawal symptoms if you stop taking it suddenly.
This medicine has been prescribed for you for the short term treatment of moderatepain. It contains meptazinol which belongs to a class of medicines called opioids, which are ‘pain relievers’. This medicine has been prescribed to you and should not be given to anyone else. Opioids can cause addiction and you may get withdrawal symptoms if you stop taking it suddenly. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.
The name of this medicine is Meptid 200 mg Film-Coated Tablets but will be referred to as Meptid Tablets throughout the remainder of the leaflet.
Talk to your prescriber before taking this medicine if you:
Taking this medicine regularly, particularly for a long time, can lead to addiction. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely. Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your prescriber about your treatment.
Addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms.
Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of opioid, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
If any of these apply to you, tell your doctor or pharmacist before you take Meptid Tablets.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
If you are taking any medicines known as monoamine-oxidase inhibitors (MAOIs) including moclobemide to treat, for example, depression, or if you have taken this type of medicine during the past two weeks, you should also talk to your doctor.
In particular, tell your doctor if you are taking, or have recently taken, any of the following medicines which are known to interact with Meptid Tablets:
Avoid taking alcohol with this medicine as it may make you feel especially dizzy and sleepy.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take Meptid Tablets during pregnancy or while breast-feeding unless your doctor thinks that it is essential.
If you take Meptid during pregnancy, your baby may become dependent and experience withdrawal symptoms after the birth which may need to be treated.
Do not take Meptid while you are breastfeeding as meptazinol passes into breast milk and will affect your baby.
If this product makes you dizzy or drowsy, you should not drive or operate machinery.
Meptid Tablets contain the colouring agent sunset yellow FCF (E 110), which may cause allergic reactions.
Your prescriber should have discussed with you, how long the course of Meptid will last.
They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is:
Swallow one tablet, with a glass of water, every four hours; your doctor may vary the dose if necessary.
If you have the impression that the effect of Meptid Tablets is too strong or too weak, talk to your doctor or pharmacist.
Do not take more than your doctor has recommended.
Long term use of Meptid Tablets may cause dependence and tolerance. If you are worried about this, talk to your doctor or pharmacist. Meptid Tablets are usually only used for short-term treatment of pain.
Meptid Tablets are not recommended for use in children.
If you think you have taken too many tablets contact your doctor or the local hospital casualty department at once. Take any remaining tablets and the packaging with you.
If you forget to take a dose at the right time, take it as soon as you remember, unless it is almost time for your next dose.
If you miss a dose completely, do not take a double dose to make up for the forgotten one. Instead, skip the missed one and take the next dose as usual.
Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop taking this medicine.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following, stop taking Meptid Tablets and contact your doctor or go to the casualty department of your nearest hospital immediately:
At the correct dose Meptid Tablets should not generally cause any problems. Talk to your doctor if you get any of the following side effects:
Very common side effects (may affect more than 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Unknown frequency: dependence and addiction (see section “How do I know if I am addicted?”).
Drug Withdrawal
When you stop taking Meptid, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.
How do I know if I am addicted?
If you notice any of the following signs whilst taking Meptid, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your prescriber
Other side effects that have not been mentioned above, but are associated with medicines that act in the same way as Meptid Tablets include:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Ireland
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of the month.
Store below 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Meptid Tablets are film-coated tablets and orange and oval shaped. The film-coated tablets are engraved with ‘MPL 023’ on one side and are available in blister packs of 6, 28, 56, 100 or 112 tablets. Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in July 2020